Probiotic Supplement as Treatment for Students With ADHD

NCT ID: NCT02908802

Last Updated: 2018-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-30

Study Completion Date

2019-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects will answer the following questionnaire and tests:

* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
* Demographic Questionnaire - composed by the researchers
* Family Eating Habits Questionnaire (FEAHQ-33)
* Food Frequency Questionnaire (FFQ)
* Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age.

Subjects will answer the following questionnaire and tests:

* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
* Demographic Questionnaire - composed by the researchers
* Family Eating Habits Questionnaire (FEAHQ-33)
* Food Frequency Questionnaire (FFQ)
* Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder (ADHD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic

Probiotic capsules: two capsules twice a day

Group Type ACTIVE_COMPARATOR

Probiotic

Intervention Type DIETARY_SUPPLEMENT

Probiotic

Placebo

Probiotic capsules without the active ingredient: two capsules twice a day

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Probiotics capsules without the active ingredient

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Probiotic

Probiotic

Intervention Type DIETARY_SUPPLEMENT

Placebo

Probiotics capsules without the active ingredient

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist,
* Students who are not treated by medication or alternative treatment,
* Students who are not due to complete their education at Tel Hai College during the study period,
* Students who have signed on an informed consent form,
* No dairy intolerance (student can consume milk without any adverse effects),
* No soy allergy,
* Not currently taking any antibiotics or probiotics,
* Not pregnant or planning to become pregnant during the study period,
* Not been diagnosed with any of the following:

* Cancer
* HIV/AIDS
* Crohn's disease
* Ulcerative colitis
* Immune compromised illness
* Other serious illness

Exclusion Criteria

* Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder,
* Students who have not been assessed by MATAL and a psychiatrist,
* Students who take antibiotics.
Minimum Eligible Age

19 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tel Hai College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Snait Tamir, Professor

Role: STUDY_DIRECTOR

[email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

40-16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.